Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 6

    1.

    Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

    Kunac DL, Kennedy J, Austin N, Reith D.

    Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005.PMID: 19301935 [PubMed - indexed for MEDLINE]Related articles

    2.

    Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.

    Kunac DL, Harrison-Woolrych M, Tatley MV.

    N Z Med J. 2008 Oct 3;121(1283):76-89. Review.PMID: 18841188 [PubMed - indexed for MEDLINE]Related articles

    3.

    The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New Zealand.

    Tatley MV, Kunac DL, McNicholas A, Zhou L, Ballantyne S, Ashton J, Stehr-Green P, Galloway Y, Reid S.

    Vaccine. 2008 May 23;26(22):2746-52. Epub 2008 Apr 1.PMID: 18430496 [PubMed - indexed for MEDLINE]Related articles

    4.

    Preventable medication-related events in hospitalised children in New Zealand.

    Kunac DL, Reith DM.

    N Z Med J. 2008 Apr 18;121(1272):17-32.PMID: 18425151 [PubMed - indexed for MEDLINE]Related articles

    5.

    Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.

    Kunac DL, Reith DM, Kennedy J, Austin NC, Williams SM.

    Qual Saf Health Care. 2006 Jun;15(3):196-201.PMID: 16751470 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Identification of priorities for medication safety in neonatal intensive care.

    Kunac DL, Reith DM.

    Drug Saf. 2005;28(3):251-61.PMID: 15733029 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...